Other

Max-planck-gesellschaft Zur F&#xf6;rderung Der Wissenschaften E. V.

Hyman, Anthony A.

Erkut, Cihan

Pan-montojo, Francisco

Kurzchalia, Teymuras

Francisco Pan-Montojo

Anthony A Hyman

Teymuras Kurzchalia

Cihan Erkut

Yusuke Toyoda

The present invention relates to glycolic acid or a pharmaceutically acceptable salt or ester thereof for use in the treatment or prevention of ischemic damage. In a preferred embodiment the present invention relates to a method for decreasing cell death caused by an ischemic insult comprising contacting glycolic acid or a pharmaceutically acceptable salt or ester thereof with hypoxic tissue, in particular cortical neurons or myocardial tissue.

Glycolic acid protects against ischemic insults

A method of treatment of a neurodegenerative disease which is associated with a decline in mitochondrial activity, includes administering to a person in need of such treatment at least one of Glycolic acid or a pharmaceutically acceptable salt or ester thereof, and D-lactic acid or a pharmaceutically acceptable salt or ester thereof.

Glycolic acid and/or D-lactic acid for the treatment of neurodegenerative diseases

The present invention relates to glycolic acid or a pharmaceutically acceptable salt or ester thereof for use in the treatment or prevention of male infertility. The present invention also relates to an ex vivo method for increasing the mobility of spermatozoa comprising contacting glycolic acid or a pharmaceutically acceptable salt or ester thereof with spermatozoa.

Glycolic acid enhances sperm mobility

Growing community of inventors

Munich, Germany

Francisco Pan-Montojo